Drug discovery

#Drug discovery #Europe #European Commission #European Union

This week in drug discovery (7-11 July) 

News round-up for 7-11 July by DDW Senior Digital Content Editor Diana Turner. This week our news highlights focus on the drug discovery in the European Union, including some new regulatory approvals from the European Commission, advancements from Netherlands-based argenx, a new PhD programme in Estonia, and Switzerland’s… Read More

#News

Automated liquid handling
#Automation / robotics #Cellular assays #Collaboration #Drug discovery #Semarion #SPT Labtech

SPT Labtech and Semarion partner on automated cell-based discovery

SPT Labtech and Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory, have announced a strategic collaboration.   The partnership will integrate SPT Labtech’s firefly liquid handling platform with Semarion’s SemaCyte microcarrier technology to develop an automated workflow to simplify and accelerate key stages of adherent cell assay development. … Read More

#Business & Investment #News

#Drug discovery #Flow Cytometry #High throughput screening #Sartorius

Sartorius introduces the iQue 5 high throughput screening platform

The life science group Sartorius has launched the new iQue 5 High-Throughput Screening (HTS) Cytometer. The iQue 5 expands experimental range with up to 27 channels (25 colour options) and flexible workflows in 96- and 384-well formats. “For scientists driving the next breakthrough in… Read More

#News

Human gastrointestinal tract
#Assays #Drug discovery #Guide #In vivo #Obesity #Weight loss

Guide: Accelerate your weight loss drug discovery

A new Guide is now available from Eurofins Discovery entitled ‘Drug Discovery for Anti-Obesity‘. Explore obesity case studies profiling semaglutide, tirzepatide, and retatrutide using Eurofins Discovery’s weight-loss solutions. Advance your obesity program with on/off-target panels, translational assays, in vivo models, and MOA-reflective tools. Partner with expert scientists and program… Read More

#News

Drug Discovery for Anti-Obesity
#Assays #Drug discovery #In vivo #Obesity #Weight loss

Accelerate your weight loss drug discovery

Explore obesity case studies profiling semaglutide, tirzepatide, and retatrutide using Eurofins Discovery’s weight-loss solutions. Advance your obesity program with on/off-target panels, translational assays, in vivo models, and MOA-reflective tools. Partner with expert scientists and program managers for strategic guidance and scientific leadership on your integrated drug discovery programs targeting weight-loss… Read More

#Resources

Antibody
#Antibodies #argenx #Biology #Biotechnology #Drug development #Drug discovery #Muscles

argenx advances ARGX-119 in congenital myasthenic syndromes 

argenx has announced it will advance ARGX-119, a first-in-class agonist antibody to muscle-specific kinase (MuSK), to a registrational study in patients with congenital myasthenic syndromes (CMS). The decision follows the analysis of topline data from the Phase Ib study, in which ARGX-119 demonstrated a favourable safety and tolerability profile. “The… Read More

#News

Tumour microenvironment
#Cancer research #Drug discovery #Insilico Medicine #Solid tumours

First patient receives novel MAT2A inhibitor for solid tumours

The first patient has been dosed in a global multicentre clinical trial to evaluate ISM3412, a potentially best-in-class, MAT2A inhibitor with novel structure, in patients with locally advanced and metastatic solid tumours. The Phase I study consists of two parts: dose escalation and dose selection optimisation, where participants will receive… Read More

#Cancer Research #News

#Biomedical research #Drug discovery #European Union #Funding #Optibrium #Sustainability

EU-Funded PhD programme to advance sustainable drug discovery

Optibrium has partnered with Tallinn University of Technology (TalTech) to co-supervise an EU-funded PhD position as part of the INNOCHEMBIO programme1. This research project will focus on developing more accurate metabolism models that will reduce the reliance on costly laboratory experiments while improving speed, efficiency and sustainability in drug discovery. Read More

#News

#Career #Drug development #Drug discovery #England #From the top #Golden Triangle #Interview #Medicines Discovery Catapult #Nanomedicine / nanotechnology #Northern Ireland #Scotland #UK #University of Oxford

New podcast: UK Spotlight: Innovation and discovery

This is the latest episode of the free DDW narrated podcast, titled “UK Spotlight: Innovation and discovery”, which covers three articles written for DDW Volume 24 – Issue 4, Fall 2023. They are called: “Where is the drug discovery expertise happening in the UK?”, “From the top: Dr… Read More

#News

#Drug discovery #Events #Milner Therapeutics Institute #Novel therapeutics

Symposium showcases innovation in translational science

On 30 June 2025, The Milner Therapeutics Institute hosted its annual symposium, a hybrid event hosted at West Road Concert Hall in Cambridge, UK, to bring together leading minds from academia and industry to showcase cutting-edge research and its translation into novel therapeutics. The day featured a line-up of speakers,… Read More

#News

Seed fund
#Artificial intelligence (AI) #Drug discovery #Genetics / genomics #OutSee #Seed funding #Start-ups

Predictive genomics pioneer OutSee raises £1.8m

OutSee has secured £1.8 ($2.4) million in seed funding, led by Ahren Innovation Capital and with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures.   The funds will support OutSee through the next phase of its growth strategy, with a focus on expanding the company’s in-house target discovery programme… Read More

#Business & Investment #News #Start-up Zone

#Drug discovery

Guide – Accelerate your weight loss drug discovery

Explore obesity case studies profiling semaglutide, tirzepatide, and retatrutide using Eurofins Discovery’s weight-loss solutions. Advance your obesity program with on/off-target panels, translational assays, in vivo models, and MOA-reflective tools. Partner with expert scientists and program managers for strategic guidance and scientific leadership on your integrated drug discovery programs targeting weight-loss… Read More

#Guides

#Artificial intelligence (AI) #Clinical trial design #Drug discovery #Lab technology #SLAS

New DDW Highlights podcast: 30 June 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. As we announce the DDW ‘Creating cures’ programme at SLAS2026, the week’s news highlights emphasise… Read More

#News

#App note #Artificial intelligence (AI) #Drug discovery #Imaging

Your AI-enhanced solution for viral infectivity analysis

Discover how the Agilent BioTek Cytation cell imaging multimode reader and ViQi’s AVIA provide a powerful, integrated solution for viral infectivity analysis. Download the application note to explore how this innovative approach offers key advantages over traditional assays, including: High-throughput, cost-effective analysis: AVIA minimises reagent use, incubation time, and replicate needs,… Read More

#Resources

#Artificial intelligence (AI) #Clinical trial design #Drug discovery #Lab technology #SLAS

This week in drug discovery (23-27 June) 

News round-up for 23-27 June by DDW Senior Digital Content Editor Diana Spencer. As we announce the DDW ‘Creating cures’ programme at SLAS2026, the week’s news highlights emphasise the importance of advanced technologies to the success of drug discovery, including digital control arms for clinical studies, nanobody-based… Read More

#News